
Urolithin C
CAS No. 165393-06-6
Urolithin C( —— )
Catalog No. M29486 CAS No. 165393-06-6
Urolithin C is a gut metabolite of ellagic acid. Urolithin C induces apoptosis in PC12 cells through a mitochondria-mediated pathway.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 43 | Get Quote |
![]() ![]() |
10MG | 72 | Get Quote |
![]() ![]() |
25MG | 131 | Get Quote |
![]() ![]() |
50MG | 222 | Get Quote |
![]() ![]() |
100MG | 335 | Get Quote |
![]() ![]() |
200MG | 494 | Get Quote |
![]() ![]() |
500MG | 782 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameUrolithin C
-
NoteResearch use only, not for human use.
-
Brief DescriptionUrolithin C is a gut metabolite of ellagic acid. Urolithin C induces apoptosis in PC12 cells through a mitochondria-mediated pathway.
-
DescriptionUrolithin C is a gut metabolite of ellagic acid. Urolithin C induces apoptosis in PC12 cells through a mitochondria-mediated pathway.(In Vitro):Urolithin C is a glucose-dependent activator of insulin secretion acting by facilitating L-type Ca2+ channel opening and Ca2+ influx into pancreatic β-cells.Urolithin C enhanced glucose-induced extracellular signal-regulated kinases 1/2 (ERK1/2) activation as shown by higher phosphorylation levels in INS-1 β-cells. Urolithin C stimulates reactive oxygen species (ROS) formation.(In Vivo):In male Wistar rat, the half-life of the terminal part is 11.3 h and the total clearance (CL/F) is 3.41 L/h/kg. The initial volume of distribution (V1/F) is 0.831 L/kg and the steady-state volume of distribution (Vss/F) is 55.6 L/kg after the intraperitoneal administration of Urolithin C (10 mg/kg).
-
In VitroWestern Blot Analysis Cell Line:INS-1 cells Concentration:20 μM, 100 μM Incubation Time:1 hour Result:Enhanced glucose-induced extracellular signal-regulated kinases 1/2 (ERK1/2) activation.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number165393-06-6
-
Formula Weight244.202
-
Molecular FormulaC13H8O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (204.75 mM)
-
SMILESOc1ccc2c(c1)oc(=O)c1cc(O)c(O)cc21
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
3,4,5-Trihydroxycinn...
3,4,5-Trihydroxycinnamic acid decyl ester, an effective inhibitor of lipid absorption and accumulation, exhibits anti-obesity properties and acts as a pancreatic lipase inhibitor, with an EC50 of approximately 0.9 μM.
-
ACBI1
ACBI1 is a potent PROTAC degrader of BAF ATPase subunits SMARCA2 and SMARCA4, also degrades the polybromo-associated BAF (PBAF) complex member PBRM1, with DC50s of 6 nM, 11 nM and 32 nM for SMARCA2, SMARCA4 and PBRM1 in MV-4-11 cells, respectively.
-
PBOX 6
PBOX 6 is a pyrrolo-1,5-benzoxazepine (PBOX) compound exhibiting anticancer and antitumor activity by inhibiting breast cancer cell growth in vitro and selectively inducing apoptosis in leukemia cells through c-Jun NH2 terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.